Cross-institution positioning
Aug 6, 2026Reduction leaning. 1 reducing across 1 comparable institution.
Source: Schedule 13 researchCORPAY, INC.
Latest stored close $402.08 as of Oct 8, 2026 View live quote ↗
See how each tracked institution's reported ownership changed across SEC position dates. Full history is available with Investor or Pro access.
What the evidence shows across the newest institutional, insider, company-event, 13F, fundamental, and price data; STOCKNODE combines these layers into a quantitative research signal while preserving each source and reporting window.
Reduction leaning. 1 reducing across 1 comparable institution.
Source: Schedule 13 research0 increased/new, 2 reduced/exited across 2 managers in the latest comparable Form 13F quarter.
Source: Form 13F quarter-end holdingsOver the last 90 days, SEC-coded non-derivative P/S activity includes 0 purchases by 0 reporting owners and 37 sales by 5 reporting owners. Amendments are shown in the filing evidence but excluded from rolling activity totals.
Source: SEC Forms 3/4/52 non-amendment material events in the last 90 days; Latest classified evidence: Results of operations / financial condition. Registration and prospectus filings are treated as financing capacity/disclosure evidence, not proof that securities were sold.
Source: SEC 8-K / securities filing metadataRevenue +21.5% YoY; Net income -12.6% YoY. Periods are compared only when the SEC facts are aligned and comparable.
Source: SEC Company FactsRecent close is 89% through its reported 52-week range; +33.7% over one year.
Source: Stored historical price seriesFiled Aug 6, 2026. Unlock the dated position comparison, disclosure classification, confidence, price context, and filing-specific significance analysis.
Premium research values are withheld until unlocked.
The research summary above gives the current read. This section shows the dated holder-level evidence behind it.
See each institution's newest reported position against its own prior report, with position as-of date separated from SEC filed date. Institution names and filing freshness remain public below.
Comparable holder direction grouped by SEC position as-of date — never presented as trade dates.
Compare each institution only with its own prior reported position. Public visitors can see who is tracked and how fresh the filing is; paid research reveals the actual comparison.
Investor and Pro reveal holder-by-holder changes, reported ownership history, dated breadth, disclosure timing, institution comparison, and filing-specific analysis without treating Schedule 13 reports as trade dates.
Reported Section 16 ownership activity. Rolling purchase/sale totals use non-derivative SEC transaction codes P and S only; amendments remain visible but are excluded from those totals.
| Date | Reporting owner | Code | Security | Shares | Price | Ownership | Filed |
|---|---|---|---|---|---|---|---|
| Aug 25, 2026 | Clarke Ronald | SOpen-market or private sale | Common Stock | 193 | $415.11 | Direct | Aug 25, 2026 |
| Aug 25, 2026 | Clarke Ronald | SOpen-market or private sale | Common Stock | 9.6K | $414.57 | Direct | Aug 25, 2026 |
| Aug 25, 2026 | Clarke Ronald | SOpen-market or private sale | Common Stock | 24.7K | $413.42 | Direct | Aug 25, 2026 |
| Aug 25, 2026 | Clarke Ronald | SOpen-market or private sale | Common Stock | 50.5K | $412.59 | Direct | Aug 25, 2026 |
| Aug 25, 2026 | Clarke Ronald | SOpen-market or private sale | Common Stock | 15.6K | $411.49 | Direct | Aug 25, 2026 |
| Aug 25, 2026 | Clarke Ronald | SOpen-market or private sale | Common Stock | 12.1K | $410.56 | Direct | Aug 25, 2026 |
| Aug 25, 2026 | Clarke Ronald | SOpen-market or private sale | Common Stock | 6.9K | $409.56 | Direct | Aug 25, 2026 |
| Aug 24, 2026 | Clarke Ronald | SOpen-market or private sale | Common Stock | 40 | $419.62 | Direct | Aug 25, 2026 |
| Aug 24, 2026 | Clarke Ronald | SOpen-market or private sale | Common Stock | 4.0K | $418.86 | Direct | Aug 25, 2026 |
| Aug 24, 2026 | Clarke Ronald | SOpen-market or private sale | Common Stock | 7.5K | $418.08 | Direct | Aug 25, 2026 |
| Aug 24, 2026 | Clarke Ronald | SOpen-market or private sale | Common Stock | 8.4K | $417.29 | Direct | Aug 25, 2026 |
| Aug 24, 2026 | Clarke Ronald | SOpen-market or private sale | Common Stock | 16.5K | $415.82 | Direct | Aug 25, 2026 |
| Aug 24, 2026 | Clarke Ronald | SOpen-market or private sale | Common Stock | 51.9K | $415.12 | Direct | Aug 25, 2026 |
| Aug 24, 2026 | Clarke Ronald | SOpen-market or private sale | Common Stock | 5.9K | $414.16 | Direct | Aug 25, 2026 |
| Aug 21, 2026 | Clarke Ronald | MExercise or conversion of derivative · derivative | Employee Stock Options | 450.0K | $0.00 | Direct | Aug 25, 2026 |
| Aug 21, 2026 | Clarke Ronald | FTax/price withholding or payment | Common Stock | 290.0K | $417.13 | Direct | Aug 25, 2026 |
| Aug 21, 2026 | Clarke Ronald | MExercise or conversion of derivative | Common Stock | 450.0K | $150.74 | Direct | Aug 25, 2026 |
| Aug 21, 2026 | King Alan | SOpen-market or private sale | Common Stock | 3.8K | $416.61 | Direct | Aug 25, 2026 |
| Aug 20, 2026 | King Alan | MExercise or conversion of derivative · derivative | Employee Stock Options | 18.4K | $0.00 | Direct | Aug 21, 2026 |
| Aug 20, 2026 | King Alan | SOpen-market or private sale | Common Stock | 258 | $415.70 | Direct | Aug 21, 2026 |
Recent 8-K item classifications plus securities registration and prospectus filings. Registration or prospectus filings show financing capacity/disclosure activity; they do not by themselves prove that securities were sold.
| Filed | Form | 8-K item(s) | Classification | Capital context | SEC |
|---|---|---|---|---|---|
| Aug 5, 2026 | 8-K | 2.02, 7.01, 9.01 | Results of operations / financial condition; Regulation FD disclosure; Financial statements / exhibits | — | Filing |
| Jul 24, 2026 | 8-K | 5.02 | Director or executive change | — | Filing |
| May 22, 2026 | 8-K | 1.01, 7.01, 9.01 | Material definitive agreement; Regulation FD disclosure; Financial statements / exhibits | — | Filing |
| May 12, 2026 | 8-K | 7.01 | Regulation FD disclosure | — | Filing |
| May 12, 2026 | 8-K | 5.07 | Shareholder vote results | — | Filing |
| May 7, 2026 | 8-K | 2.02, 7.01, 9.01 | Results of operations / financial condition; Regulation FD disclosure; Financial statements / exhibits | — | Filing |
| Apr 27, 2026 | 8-K | 7.01, 9.01 | Regulation FD disclosure; Financial statements / exhibits | — | Filing |
| Feb 26, 2026 | 8-K | 5.08, 8.01 | Shareholder director nominations; Other event | — | Filing |
| Feb 5, 2026 | 8-K/AAmendment | 2.01, 9.01 | Acquisition or disposition of assets; Financial statements / exhibits | — | Filing |
| Feb 4, 2026 | 8-K | 2.02, 7.01, 9.01 | Results of operations / financial condition; Regulation FD disclosure; Financial statements / exhibits | — | Filing |
| Jan 22, 2026 | 8-K | 5.02, 9.01 | Director or executive change; Financial statements / exhibits | — | Filing |
| Nov 5, 2025 | 8-K | 1.01, 2.01, 2.02, 2.03, 7.01, 9.01 | Material definitive agreement; Acquisition or disposition of assets; Results of operations / financial condition; New direct financial obligation; Regulation FD disclosure; Financial statements / exhibits | Debt | Filing |
Period-aligned SEC facts. Comparisons appear only when periods and units are comparable.
| Period | Revenue | YoY |
|---|---|---|
| Ended Jun 30, 2026 | $1.3B | +21.5% |
| Ended Mar 31, 2026 | $1.3B | +25.4% |
| Ended Sep 30, 2025 | $1.2B | +13.9% |
| Ended Jun 30, 2025 | $1.1B | +12.9% |
| Period | Revenue | YoY |
|---|---|---|
| Ended Dec 31, 2025 | $4.5B | +13.9% |
| Ended Dec 31, 2024 | $4.0B | +5.8% |
| Ended Dec 31, 2023 | $3.8B | +9.6% |
| Ended Dec 31, 2022 | $3.4B | +20.9% |
Dated price context from the historical market series already collected for this security.
Returns are close-to-close price changes. Volatility and drawdown are factual historical context, not recommendations.
Schedule 13G/13D reports beneficial ownership at an observation date. “Accumulation” or “reduction” is inferred from changes in reported shares when available; it is not a list of individual trades or exact execution prices.
Form 13F rows are quarter-end holding context only and do not establish an exact entry date.
For more context, see how to read a Schedule 13G, filing date vs event date, or Schedule 13G vs Schedule 13D.
| Holder | Observed / filed | Reported change | Shares | Ownership | Observation | Filing | Latest |
|---|---|---|---|---|---|---|---|
| Vanguard Capital Management CIK0002100119 | Jun 30, 2026 quarter end Aug 13, 2026 filed Form 13F quarter-end evidence | Earlier Form 13F quarter-end holding Quarter-end holding evidence; no ownership percentage or signal. | 4.2M | $402.08 | |||
| Fidelity / FMR CIK0000315066 | Jun 30, 2026 observed Aug 6, 2026 filed · 37d Initial Schedule 13G | Initial Schedule 13G | 3.6K | 5.50% | $333.27 | $398.28 | $402.08 |
| Vanguard Capital Management CIK0002100119 | Mar 31, 2026 observed Apr 29, 2026 filed · 29d Initial Schedule 13G | Initial Schedule 13G | 5.1M | 7.51% | $290.99 | $306.98 | $402.08 |
Compare CPAY with other securities showing similar institutional activity or recent accumulation across several tracked institutions.